SCHEMBL18002608

SCHEMBL18002608

CC(C)Oc1cc(C=O)cc(-c2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A3 P47895 1/20 0.51
▸ RXRA P19793 1/20 0.48
▸ RXRB P28702 1/20 0.48
▸ DRD1 P21728 1/20 0.44
▸ ERN1 O75460 1/20 0.42
▸ PTPN5 P54829 1/20 0.41
▸ GABRA1 P14867 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ GABRB3 P28472 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ ABCB1 P08183 1/20 0.40
▸ FFAR4 Q5NUL3 4/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26683191 0.84 RXRA (0.46) ALDH1A3RXRARXRBDRD1ERN1
SCHEMBL5069234 0.81 CYP2A6 (0.50) RXRAERN1ABCB1MEN1MAPT
SCHEMBL12037831 0.80 ALDH1A3 (0.63) ALDH1A3DRD1ERN1KMT2ASIRT1
SCHEMBL1121444 0.80 ALDH1A3 (0.63) ALDH1A3DRD1ERN1KMT2ASIRT1
SCHEMBL3232564 0.80 ALDH1A3 (0.44) ALDH1A3RXRARXRBDRD1ERN1
SCHEMBL18002195 0.79 ALDH1A3 (0.46) ALDH1A3ERN1MEN1KMT2APKM
SCHEMBL18002510 0.77 RXRA (0.47) RXRARXRBERN1MAPTSMN1; SMN2
SCHEMBL7902633 0.76 ALDH1A1 (0.55) DRD1MEN1MAPTKMT2ALMNA
SCHEMBL1664238 0.76 ALDH1A1 (0.55) DRD1MEN1MAPTKMT2ALMNA
SCHEMBL17592759 0.75 FFAR4 (0.76) FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2016-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160229816-A1 CYANOTRIAZOLE COMPOUNDS CS, PC, ACAT1 ALDH1A3 2589/4885RXRA 3077/4885RXRB 2771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback